BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10424771)

  • 1. Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases.
    Leader H; Vincze A; Manisterski B; Rothschild N; Dosoretz C; Ashani Y
    Biochem Pharmacol; 1999 Aug; 58(3):503-15. PubMed ID: 10424771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators.
    Ashani Y; Bhattacharjee AK; Leader H; Saxena A; Doctor BP
    Biochem Pharmacol; 2003 Jul; 66(2):191-202. PubMed ID: 12826262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of organophosphorus hydrolase and oxime on the reactivation rate of diethylphosphoryl-acetylcholinesterase conjugates.
    Ashani Y; Leader H; Rothschild N; Dosoretz C
    Biochem Pharmacol; 1998 Jan; 55(2):159-68. PubMed ID: 9448738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
    Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
    Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Organophosphate Ligand O-(2-Fluoroethyl)-O-(p-Nitrophenyl)Methylphosphonate: Synthesis, Hydrolytic Stability and Analysis of the Inhibition and Reactivation of Cholinesterases.
    Chao CK; Ahmed SK; Gerdes JM; Thompson CM
    Chem Res Toxicol; 2016 Nov; 29(11):1810-1817. PubMed ID: 27551891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands.
    Luo C; Ashani Y; Doctor BP
    Mol Pharmacol; 1998 Apr; 53(4):718-26. PubMed ID: 9547363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning.
    Saxena A; Maxwell DM; Quinn DM; Radić Z; Taylor P; Doctor BP
    Biochem Pharmacol; 1997 Jul; 54(2):269-74. PubMed ID: 9271331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amidine-oximes: reactivators for organophosphate exposure.
    Kalisiak J; Ralph EC; Zhang J; Cashman JR
    J Med Chem; 2011 May; 54(9):3319-30. PubMed ID: 21438612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
    Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
    Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure.
    Nigg HN; Knaak JB
    Rev Environ Contam Toxicol; 2000; 163():29-111. PubMed ID: 10771584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel.
    Hanke DW; Overton MA
    J Toxicol Environ Health; 1991 Sep; 34(1):141-56. PubMed ID: 1890690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of model cholinesterases by oximes and intermediate phosphyloximes: a computational study.
    Vyas S; Hadad CM
    Chem Biol Interact; 2008 Sep; 175(1-3):187-91. PubMed ID: 18582852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase.
    Luo C; Leader H; Radic Z; Maxwell DM; Taylor P; Doctor BP; Saxena A
    Biochem Pharmacol; 2003 Aug; 66(3):387-92. PubMed ID: 12907237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design.
    Hammond PI; Kern C; Hong F; Kollmeyer TM; Pang YP; Brimijoin S
    J Pharmacol Exp Ther; 2003 Oct; 307(1):190-6. PubMed ID: 12893843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes.
    Caranto GR; Waibel KH; Asher JM; Larrison RW; Brecht KM; Schutz MB; Raveh L; Ashani Y; Wolfe AD; Maxwell DM
    Biochem Pharmacol; 1994 Jan; 47(2):347-57. PubMed ID: 8304979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of interactions of amodiaquine with human cholinesterases and organophosphorus compounds.
    Bierwisch A; Wille T; Thiermann H; Worek F
    Toxicol Lett; 2016 Mar; 246():49-56. PubMed ID: 26851641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.